MIRA INFORM REPORT

 

 

Report No. :

345870

Report Date :

19.10.2015

 

IDENTIFICATION DETAILS

 

Name :

PUNJAB CHEMICALS AND CROP PROTECTION LIMITED

 

 

Registered Office :

SCO 183, 1st Floor, Sector 26, Madhya Marg, Chandigarh - 160019

Tel. No.:

91-172-5008300/ 301

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

19.11.1975

 

 

Com. Reg. No.:

003603

 

 

Capital Investment / Paid-up Capital :

Rs. 122.600 Million

 

 

CIN No.:

[Company Identification No.]

L24231CH1975PLC003603

 

 

IEC No.:

2288000988

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACP9904H 

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Agro Chemicals, Speciality Chemicals and Bulk Drugs and its Intermediates.

 

 

No. of Employees :

818 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 547700

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Exist

 

 

Comments :

Subject is an old company incorporated in 1975.

 

The rating takes into consideration moderate financial risk profile of the company marked by leveraged capital structure in FY15, however it has improved against previous year. Further its minimal reserve level and the reduction in the cash level act as a threat to the liquidity position of the company.

 

However, management has reported improvement in its operational level by earning acceptable profit in the year under consideration. Overall financial condition of the company is improving.

 

The company’s shares are listed on National Stock Exchange and has been traded which the price of nearly Rs. 211/- as on the date 19th October 2015.

 

However, trade relations are fair. Business is active. Payment terms are reported to be slow but correct.

 

The company can be considered for business dealings with usual trade terms and conditions. 

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Punit Kumar Abrol

Designation :

Senior Vice President Finance

Contact No.:

91-22-26747900

Date :

17.10.2015

 

 

LOCATIONS

 

Registered Office :

SCO 183, 1st Floor, Sector 26, Madhya Marg, Chandigarh – 160019, India

Tel. No.:

91-172-5008300/ 301

Fax No.:

91-172-2790160

E-Mail :

info@punjabchemicals.com

Website :

http://www.punjabchemicals.com

 

 

Corporate Office :

Oberoi Chambers II, 5th Floor, 645/646, New Link Road, Andheri (West), Mumbai 400053, Maharashtra, India

Tel. No.:

91-22-26747900 (30 Lines)

Fax No.:

91-22-26736193/ 78

E-Mail :

enquiry@punjabchemicals.com

 

 

Factory 1 :

Agro-Chemicals Division

Milestone-18, Ambala Kalka Road, P.O. Bhankharpur, District SAS Nagar, Mohali – 140201, Punjab, India

Tel. No.:

91-1762-280086/ 280094/ 522253

Fax No.:

91-1762-280070

E-Mail :

factoryinfo@punjabchemicals.com

 

 

Factory 2 :

Pharma Division - Unit Alpha Drug

Villages: Kolimajra and Samalheri, P.O.: Lalru, District SAS Nagar Mohali, Punjab, India

Tel. No.:

91-1762-275519/ 506996

Fax No.:

91-1762-275308/ 506999

E-Mail :

pharmainfo@punjabchemicals.com

 

 

Other Factories :

Located at:

 

·         Agro Chemicals Division - PCCPL, Derabassi

Vadodara

Tarapur

Industrial Chemicals Division, Pune

Chiplun

 

 

Marketing Offices :

Located at:

 

·         New Delhi

Ahmedabad

Vadodara

Hyderabad

Chennai

 

 

DIRECTORS

 

AS ON 31.03.2015

 

Name :

Ghattu Ramanna Narayan (w.e.f May 28, 2015)

Designation :

Chairman Emeritus

 

 

Name :

Mr. Mukesh Dahyabhai Patel

Designation :

Chairman

Date of Appointment :

28.05.2015

 

 

Name :

Shalil Shashikumar Shroff

Designation :

Managing Director

 

 

Name :

Capt. Surjit Singh Chopra (Retd.)

Designation :

Director

 

 

Name :

Mr. Vijay Dilbagh Rai

Designation :

Director

 

 

Name :

Sindhu Seth

Designation :

Director

 

 

Name :

Sheo Prasad Singh

Designation :

Additional Director

Date of Birth/Age :

28.04.1952

Qualification :

M sc., CAIIB, PGDFRM, PGDFA

Expertise in specific functional area :

Commercial Banking including, Treasury, Direct/Indirect Taxation, management of Superannuation Funds

Date of Appointment :

11.02.2015

DIN No.:

06493455

 

 

Name :

Mr. Avtar Singh

Designation :

Director (Operations and Business Development)

Date of Birth/Age :

04.10.1958

Qualification :

B. Sc

Expertise in specific functional area :

He is a Whole Time Director and incharge of Agro Chemicals Division, Derabassi and Pharma Division, Lalru in District Mohali, Punjab. His expertise is in Research and development, production and marketing of chemicals. He is also involved in setting up and maintenance of plants in these sites.

Date of Appointment :

14.11.1996

DIN No.:

00063569

Other Directorship :

Saurav Chemicals Limited

 

 

Name :

Mr. Shivshankar Shripal Tiwari

Designation :

Additional Director

Date of Birth/Age :

30.08.1953

Qualification :

M.Sc., Post graduate Diploma-Business Management

Expertise in specific functional area :

He is experienced in managing the chemical plants, production, manpower and domestic commercial market of chemicals.

Date of Appointment :

28.05.2015

DIN No.:

00019058

 

 

KEY EXECUTIVES

 

Name :

Mr. Punit Kumar Abrol

Designation :

Senior Vice President Finance and Company Secretary

 

 

Name :

Mr. Vipul Joshi

Designation :

Chief Financial Officer

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2015

 

Category of Shareholder

Total No. of Shares

As a %

(A) Shareholding of Promoter and Promoter Group

 

 

(1) Indian

 

 

Individuals / Hindu Undivided Family

891572

7.27

Bodies Corporate

4602295

37.53

Sub Total

5493867

44.80

(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

5493867

44.80

(B) Public Shareholding

 

 

(1) Institutions

 

 

Mutual Funds / UTI

6432

0.05

Financial Institutions / Banks

4699

0.04

Central Government / State Government(s)

122027

1.00

Insurance Companies

15742

0.13

Foreign Institutional Investors

3913

0.03

Sub Total

152813

1.25

(2) Non-Institutions

 

 

Bodies Corporate

3619393

29.52

Individuals

 

 

Individual shareholders holding nominal share capital up to Rs. 0.100 Million

2176217

17.75

Individual shareholders holding nominal share capital in excess of Rs. 0.100 Million

361995

2.95

Any Others (Specify)

457900

3.73

Foreign Portfolio Investors

324676

2.65

Directors & their Relatives & Friends

56318

0.46

Non Resident Indians

76614

0.62

Trusts

292

0.00

Sub Total

6615505

53.95

Total Public shareholding (B)

6768318

55.20

Total (A)+(B)

12262185

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

(1)

0

0.00

(2)

0

0.00

Sub Total

0

0.00

Total (A)+(B)+(C)

12262185

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Agro Chemicals, Speciality Chemicals and Bulk Drugs and its Intermediates.

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

No. of Employees :

818 (Approximately)

 

 

Bankers :

Bank Name:

Not Divulged

Branch:

Not Divulged

Person Name (with Designation):

Not Divulged

Contact Number:

Not Divulged

Name of Account Holder:

Not Divulged

Account Number:

Not Divulged

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Divulged

Account Operation:

Not Divulged

Remarks:

Not Divulged

 

·         State Bank of India

Bank of Baroda

Export-Import Bank of India

Allahabad Bank

Union Bank of India

Central Bank of India

 

 

Facilities :

SECURED LOANS

31.03.2015

(Rs. In Million)

31.03.2014

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Term loans

From banks

Term loan

1147.600

1639.800

From others

Housing finance scheme

1.400

1.700

SHORT TERM BORROWINGS

 

 

Cash credit from banks

730.000

754.300

Working capital demand loan from banks

138.500

200.000

 

 

 

Total

 

2017.500

2595.800

 

LONG-TERM BORROWINGS

a)       In accordance with the Corporate Debt Restructuring Scheme (CDR) approved by the Corporate Debt Restructuring Empowered Group, SBICAP Trustee Company Limited was appointed as the Security Trustee for the benefit of the Lenders of the Company and acting as an agent for SBI Antwerp, Belgium for the loan taken by one of the subsidiary of the Company. In pursuance of master restructuring agreement signed as per CDR scheme and the SBI Antwerp document, the term loan amounting to Rs. 1724.200 Million (Previous year Rs. 1891.900 Million) and working capital demand loan amounting to Rs. 149.200 Million (Previous year Rs. 289.000 Million) is secured by way of first pari passu charge on movable assets including current assets and immovable assets of Agro and Pharma Division, pledge of unencumbered shares of one of the promoter and the personal guarantee of promoter of the Company. Further, Working Capital Term Loan amounting to Rs. Nil (Previous year Rs. 10.600 Million) from Indian Overseas Bank was secured by exclusive charge by hypothecation of plant and equipments, inventories, and book debts and pledge of factory building and office premises at Vadodara.

 

b)       Term Loans amounting to Rs. 756.500 Million (Previous year: Rs. 847.400 Million) is carrying interest rate of 10.75% p.a. (Previous year 10.75% p.a.). Principal amount of Rs. 19.400 Million (Previous year: Rs. 18.500 Million) is overdue for a period of 1 to 821 days (Previous year 1 to 456 days) as on the reporting date.

 

c)       Working Capital Term Loans amounting to Rs. 525.400 Million (Previous year: Rs. 572.900 Million) is carrying interest rate of 8% p.a. (Previous year 8% p.a.). Principal amount of Rs. 37.000 Million (Previous year: Rs. 22.700 Million) is overdue for a period of 1 to 821 days (Previous year 1 to 456 days) as on the reporting date.

 

d)       Funded Interest Term Loan amounting to Rs. 442.300 Million (Previous year: Rs. 482.200 Million) is carrying interest rate of 8% p.a. (Previous year 8% p.a.). Principal amount of Rs. 16.900 Million (Previous year: Rs. 7.100 Million) is overdue for a period of 1 to 548 days (Previous year 1 to 183 days) as on the reporting date.

 

e)       Working Capital Demand Loans amounting to Rs. 149.200 Million (Previous year: Rs. 289.000 Million) is carrying interest rate of 10.75% p.a. (Previous year 10.75% p.a.). Principal amount of Rs. 149.200 Million (Previous year: Rs. 289.000 Million) is overdue for 913 days (Previous year 548 days) as on the reporting date.

 

f)         Housing Loan form ICICI Bank Limited amounting to Rs.0.100 lac (Previous year: Rs. 2.500 Million) is secured by a first charge by way of mortgage of residential flat situated at Mumbai and is carrying interest rate ranging from 12% - 16% p.a. (Previous year 12%-16% p.a.) and is repayable in 143 EMIs.

 

g)       Loan from Housing Development Finance Corporation Limited for Rs. 1.700 Million (Previous year: Rs. 2.200 Million) is secured by equitable mortgage by way of the deposit of the title deeds of the properties of respective employees who have availed the loan under said Schemes and is carrying interest rate of 12% - 16% p.a. (Previous year 12%-16% p.a.) and is repayable in 144 EMIs.

 

h)       Deposits from public and shareholders were unsecured and carried interest rate ranging from 11% - 15% p.a. (Previous year 11%-15% p.a.) which have been repaid during the current year.

 

SHORT TERM BORROWINGS

a)       In accordance with the Corporate Debt Restructuring Scheme (CDR) approved by the Corporate Debt Restructuring Empowered Group, SBICAP Trustee Company Limited was appointed as the Security Trustee for the benefit of the Lenders of the Company and acting as an agent for SBI Antwerp, Belgium for the loan taken by one of the subsidiary of the Company. In pursuance of master restructuring agreement signed as per CDR scheme and the SBI Antwerp document, the cash credit amounting to Rs. 730.000 Million (Previous year: Rs. 737.800 Million) and working capital demand loan amounting to Rs. 138.500 Million (Previous year: Rs. 200.000 Million) is secured by way of first pari passu charge on movable assets including current assets and immovable assets of Agro and Pharma Division, pledge of unencumbered shares of one of the promoter and the personal guarantee of promoter of the Company. Further, Cash Credit amounting to Rs. Nil (Previous year: Rs 16.500 Million) from Indian Overseas Bank was secured by exclusive charge by hypothecation of plant and machineries, stock and book debts and pledge of factory building and office premises at Vadodara.

 

b)       Cash Credit amounting to Rs. 730.000 Million (Previous year: Rs. 754.300 Million) is carrying interest rate of 10.75% p.a. (Previous year 10.75% p.a.).

 

c)       Working Capital Demand Loans amounting to Rs. 138.500 Million (Previous year: Rs. 200.000 Million) is carrying interest rate of 10.25% p.a. (Previous year 10.25% p.a).

 

d)       Inter-corporate deposits amounting to Rs. 78.700 Million (Previous year: Rs. 78.700 Million) is carrying interest rate of 12.75% p.a (Previous year 12.75% p.a).

 

Banking Relations :

--

 

 

Statutory Auditors :

 

Name :

S R B C and Company LLP

Chartered Accountants

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Subsidiaries :

·         STS Chemicals (UK) Limited

S D Agchem (Europe) NV

Sintesis Quimica. S.A.I.C., Argentina

 

 

Joint venture company :

Stellar Marine Paints Limited

 

 

Enterprises over which key management personnel & their relatives have significant influence :

·         Hemsil Trading and Manufacturing Private Limited

Salil Meta Chem

L & L Products Shroff Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

19,800,000

Equity Shares

Rs. 10/- each

Rs. 198.000 Million

20,000

9.8% Redeemable Cumulative Preference Shares

Rs. 100/- each

Rs. 2.000 Million

 

 

 

 

 

Total

 

Rs. 200.000 Million

 

Issued Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

12,277,218

Equity Shares

Rs. 10/- each

Rs. 122.800 Million

 

 

 

 

 

Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

12,262,185

Equity Shares

Rs. 10/- each

Rs. 122.600 Million

 

 

 

 

 

Reconciliation of the shares outstanding at the beginning and at the end of the reporting year

 

Equity shares

 

31 March 2015

 

Numbers

Rs. in Million

 

 

 

At the beginning and at the end of the year

1,22,62,185

122.600

 

Terms/rights attached to equity shares

 

The company has only one class of equity shares having a par value of Rs. 10 per share. Each holder of equity shares is entitled to one vote per share.

 

In the event of liquidation of the company, the holders of the equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

 

Aggregate number of bonus shares issued, shares issued for consideration other than cash and shares bought back during the period of five years immediately preceding the reporting date

 

 

31 March 2015

In numbers

31 March 2014

In numbers

 

 

 

Equity shares allotted as fully paid-up pursuant to a scheme of amalgamation for consideration other than cash in 2011-12

69,293

69,293

 

Details of shareholders holding more than 5% shares in the company

 

Name of the shareholders

 

31 March 2015

Equity shares of Rs. 10 each fully paid-up

Numbers

% holding

Hem-sil Trading and Manufacturing Private Limited

40,17,318

32.76%

Gowal Consulting Services Private Limited

30,00,000

24.47%

 

As per records of the company, including its register of shareholders/members and other declarations received from shareholders regarding beneficial interest, the above shareholding represents both legal and beneficial ownership of shares.


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

122.600

122.600

122.600

(b) Reserves & Surplus

69.100

65.600

54.200

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

191.700

188.200

176.800

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

1149.000

1641.500

1811.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

98.500

79.400

64.400

Total Non-current Liabilities (3)

1247.500

1720.900

1875.400

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

947.200

1033.000

839.000

(b) Trade payables

602.000

705.500

626.400

(c) Other current liabilities

1138.700

977.900

803.600

(d) Short-term provisions

76.700

75.900

72.200

Total Current Liabilities (4)

2764.600

2792.300

2341.200

 

 

 

 

TOTAL

4203.800

4701.400

4393.400

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2074.500

2186.600

2286.400

(ii) Intangible Assets

131.600

148.800

158.300

(iii) Capital work-in-progress

56.000

5.300

76.000

(iv) Intangible assets under development

11.500

6.600

6.300

(b) Non-current Investments

34.800

33.800

34.300

(c) Deferred tax assets (net)

302.600

190.400

199.400

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

45.800

55.900

34.700

Total Non-Current Assets

2656.800

2627.400

2795.400

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.300

0.000

0.000

(b) Inventories

571.900

658.400

482.800

(c) Trade receivables

586.600

682.100

688.600

(d) Cash and cash equivalents

64.700

238.200

81.900

(e) Short-term loans and advances

250.800

316.800

306.700

(f) Other current assets

72.700

178.500

38.000

Total Current Assets

1547.000

2074.000

1598.000

 

 

 

 

TOTAL

4203.800

4701.400

4393.400

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Revenue from Operations

4097.100

4168.600

2006.100

 

 

Other Income

105.700

162.800

38.000

 

 

TOTAL                                     (A)

4202.800

4331.400

2044.100

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

2324.900

2325.500

1052.900

 

 

Purchases of Stock-in-Trade

33.600

121.500

25.400

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

32.500

(138.400)

50.500

 

 

Employees benefits expense

438.400

471.000

200.800

 

 

Other expenses

823.300

1033.000

563.600

 

 

Exceptional Items

21.700

33.800

(73.700)

 

 

TOTAL                                     (B)

3674.400

3846.400

1819.500

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

528.400

485.000

224.600

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

317.000

324.800

173.600

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

211.400

160.200

51.000

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

175.800

148.400

71.700

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

35.600

11.800

-20.700

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

35.600

11.800

-20.700

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of Goods (FOB basis)

2880.700

1687.200

260.000

 

 

Interest on overdue balances, loans, advances, etc.

0.000

0.000

0.017

 

 

Processing charges received

5.700

226.700

151.500

 

 

Technical support and development fees

2.800

3.200

0.000

 

 

Others

0.200

0.100

0.000

 

TOTAL EARNINGS

2889.400

1917.200

411.517

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

645.200

 520.300

132.900

 

 

Components and spare parts

0.300

0.000

0.000

 

 

Traded goods

11.500

9.300

0.000

 

 

Capital Goods

0.000

0.300

0.700

 

TOTAL IMPORTS

657.000

529.900

133.600

 

 

 

 

 

 

Earnings Per Share (Rs.)

2.91

0.96

(1.69)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2015

31.03.2014

31.03.2013

Current maturities of Long term borrowings

726.200

557.400

440.700

 

 

 

 

Cash generated from operations

493.100

376.700

271.100

 

 

 

 

Net cash generated from operating activities

484.400

360.400

240.200

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

30.06.2015

Type

1st Quarter

Net Sales

666.100

Total Expenditure

667.600

PBIDT (Excl OI)

(1.500)

Other Income

44.200

Operating Profit

42.700

Interest

55.400

Exceptional Items

0.000

PBDT

(12.700)

Depreciation

41.700

Profit Before Tax

(54.400)

Tax

0.000

Provisions and contingencies

0.000

Profit After Tax

(54.400)

Extraordinary Items

0.000

Prior Period Expenses

0.000

Other Adjustments

0.000

Net Profit

(54.400)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

0.87

0.28

(1.03)

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

12.90

11.63

11.20

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.94

0.26

(0.51)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.19

0.06

(0.12)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

14.72

17.17

17.48

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.56

0.74

0.68

 

 

STOCK PRICES

 

Face Value

Rs. 10/-

 

 

Market Value

Rs. 211.20/- [BSE]

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particulars

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

122.600

122.600

122.600

Reserves & Surplus

54.200

65.600

69.100

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

176.800

188.200

191.700

 

 

 

 

Long-term borrowings

1811.000

1641.500

1149.000

Short term borrowings

839.000

1033.000

947.200

Current maturities of Long term borrowings

440.700

557.400

726.200

Total borrowings

3090.700

3231.900

2822.400

Debt/Equity ratio

17.481

17.173

14.723

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

2006.100

4168.600

4097.100

 

 

107.796

-1.715

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

2006.100

4168.600

4097.100

Profit/ (Loss)

(20.700)

11.800

35.600

 

(1.03%)

0.28%

0.87%

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

Yes

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 


LITIGATION DETAILS

 

Case Details For Case CP-82-2013

Diary Number

1006038

District

UT-CHANDIGARH

Category

21-COMPANY PETITIONS

Main Case Detail

--

Party Detail

REPAR CORPORATION V/S PUNJAB CHEMICALS & CROP PROTECTION LTD

Advocate Name

RAINA SABHARWAL THAKUR

List Type

LIQUIDATION

Status

PENDING

Next date

25-JAN-2016

Miscellaneous Applications

CA-168-2014     View Order Dated 31-03-2014

IN CP-82-2013

CA-268-2013

IN CP-82-2013

CA-674-2014     View Order Dated 16-01-2015

IN CP-82-2013

 

Case Listing Details

Cause List Date

List Type: Sr. No.

Bench

Order Link

22-SEP-2015

LIQUIDATION:7

HON'BLE MR. JUSTICE RAJESH BINDAL

View Interim Order

26-MAY-2015

PROUNCEMENT:

HON'BLE MR. JUSTICE AMIT RAWAL

View Interim Order

25-MAY-2015

LIQUIDATION:8

HON'BLE MR. JUSTICE AMIT RAWAL

----

21-APR-2015

LIQUIDATION:12

HON'BLE MR. JUSTICE AMIT RAWAL

----

13-FEB-2015

LIQUIDATION:12

HON'BLE MR. JUSTICE RAJESH BINDAL

View Interim Order

16-JAN-2015

LIQUIDATION:17

HON'BLE MR. JUSTICE RAJESH BINDAL

View Interim Order

11-NOV-2014

LIQUIDATION:12

HON'BLE MR. JUSTICE RAJESH BINDAL

----

30-SEP-2014

LIQUIDATION:10

HON'BLE MR. JUSTICE RAJESH BINDAL

View Interim Order

14-JUL-2014

LIQUIDATION:7

HON'BLE MR. JUSTICE RAJIV NARAIN RAINA

View Interim Order

31-MAR-2014

LIQUIDATION:19

HON'BLE MR. JUSTICE RAJIV NARAIN RAINA

View Interim Order

27-JAN-2014

LIQUIDATION:15

HON'BLE MR. JUSTICE RAJIV NARAIN RAINA

View Interim Order

22-JAN-2014

LIQUIDATION:14

HON'BLE MR. JUSTICE RAJIV NARAIN RAINA

----

26-SEP-2013

LIQUIDATION:22

HON'BLE MR. JUSTICE SURYA KANT

----

29-MAY-2013

NA:110

HON'BLE MR. JUSTICE SURYA KANT

View Interim Order

Details of Copy Petition Applied in CP-82-2013

Petition Type/No

Petition Date

Applied By

Petition Status

 

 

 

 

 :219885

 30-MAY-2013

 Advocate/Clerk
PARDEEP SINGH/RAINA SABHARWAL 9501010404

 Delivered

 :279224

 03-OCT-2013

 Advocate/Clerk
PARDEEP SINGH RAINA SABHARWAL THAKUR 9501010404

 Delivered

 Urgent:329960

 28-JAN-2014

 Advocate/Clerk
PARDEEP SINGH/RAINA SABHARWAL THAKUR

 Delivered

 Ordinary:555014

 27-MAY-2015

 Advocate/Clerk
V.K. SAINI / SIVINEET SHARMA

 Delivered

Judgment Details For Case: CP-82-2013 
Party Detail: REPAR CORPORATION V/S PUNJAB CHEMICALS & CROP PROTECTION LTD

Order Date

Order Type

Bench

Judgment Link

22-SEP-15

Interim Order

HON'BLE MR. JUSTICE RAJESH BINDAL

View Order

26-MAY-15

Interim Order

HON'BLE MR. JUSTICE AMIT RAWAL

View Order

13-FEB-15

Interim Order

HON'BLE MR. JUSTICE RAJESH BINDAL

View Order

16-JAN-15

Interim Order

HON'BLE MR. JUSTICE RAJESH BINDAL

View Order

30-SEP-14

Interim Order

HON'BLE MR. JUSTICE RAJESH BINDAL

View Order

14-JUL-14

Interim Order

HON'BLE MR. JUSTICE RAJIV NARAIN RAINA

View Order

31-MAR-14

Interim Order

HON'BLE MR. JUSTICE RAJIV NARAIN RAINA

View Order

27-JAN-14

Interim Order

HON'BLE MR. JUSTICE RAJIV NARAIN RAINA

View Order

29-MAY-13

Interim Order

HON'BLE MR. JUSTICE SURYA KANT

View Order

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10483096

21/08/2015 *

202,100,000.00

STATE BANK OF INDIA

KORTE HERENTALSESTRAAT 3, 2018 ANTWERPEN 1, BELGIUM, - 0032, BELGIUM

C64225501

2

10325860

21/08/2015 *

3,556,400,000.00

SBICAP TRUSTEE COMPANY LIMITED

202, MAKER TOWER, 'E', CUFFE PARADE, COLABA, MUMBAI, MAHARASHTRA - 400005, INDIA

C64225790

3

10297302

28/06/2011

250,000,000.00

CENTRAL BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, CHANDER MUKHI, GROUND 
FLOOR, NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA

B16882680

4

10255054

25/09/2010

500,000,000.00

ALLAHABAD BANK

GROUND FLOOR,37, MUMBAI SAMACHAR MARG, FORT, MUMBAI, MAHARASHTRA - 400023, INDIA

A98852320

5

10242441

15/09/2010

2,802,800,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH SNEHAL CHEMBER, TELLI GALLI ,ANDHERI EAST, MUMBAI, MAHARASHTRA - 400069, INDIA

A95633616

6

10242811

15/09/2010

2,130,000,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, SNEHAL CHAMBERS, TELLI 
GALLI, ANDHERI (EAST), MUMBAI, MAHARASHTRA - 400069, INDIA

A95961819

7

10213781

29/03/2010

500,000,000.00

ALLAHABAD BANK

37, MUMBAI SAMACHAR MARG, FORT BRANCH, MUMBAI, MAHARASHTRA - 400023, INDIA

A83631200

8

10201437

17/02/2010

250,000,000.00

CENTRAL BANK OF INDIA

NARIMAN POINT BRANCH,CHANDRAMUKHI BLD, GR FLOOR, NARIMAN POINT, MUMBAI, MAHARASHTRA - 400021, INDIA

A79116372

9

10182401

24/09/2009

250,000,000.00

UNION BANK OF INDIA

CORPORATE & SME BRANCH, ADISHANKARACHARYA MARG,OPP. POWAI LAKE, POWAI, MUMBAI, MAHARASHTRA - 400072, INDIA

A71748602

10

10109569

03/04/2008

850,000,000.00

EXPORT- IMPORT BANK OF INDIA

FLOOR 21, CENTRE ONE BUILDING, WORLD TRADE CENTRE COMPLEX, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

A40695124

11

10064334

20/07/2007

310,000,000.00

EXPORT IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21, WORLD TRADE CENTRE 
COMPLEX, CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDIA

A21555867

12

90160338

20/02/2004 *

10,000,000.00

BANK OF BARODA

INTERNATIONAL BUSINESS BRANCH, GENERAL J BHOSALE 
MARG, MUMBAI, MAHARASHTRA - 400021, INDIA

-

13

90160183

20/05/2003

18,400,000.00

ICICI BANK LIMITED

ICICI BANK TOWAR, BANDRA KURLA COMPLEX, MUMBAI, MAHARASHTRA - 400051, INDIA

-

14

90231073

24/03/2006 *

100,000,000.00

BANK OF BARODA

INTERNATIOANL BUSINESS BRANCH, GENERAL J.BHOSALE 
MARG,, MUMBAI, MAHARASHTRA - 400021, INDIA

-

15

90159956

24/09/2000

10,000,000.00

BANK OF BARODA

INTERNATIONAL BUSINESS BRANCH, GENERAL J BHOSALE 
MARG, MUMBAI, MAHARASHTRA - 400021, INDIA

-

16

90231059

13/03/2009 *

1,203,000,000.00

BANK OF BARODA

P.B. NO11745, FORESHORE BUILDING, GEN. BHOSLE MARG, NR. SACHIVALAYA GYMKHANNA, NARIMAN POINT MUMBAI, 
MAHARASHTRA - 400021, INDIA

A61431425

17

90159921

30/12/2003 *

10,000,000.00

BANK OF BARODA

INTERMATIONAL BUSINESS BRANCH, GENERAL J BHOSALE 
MARG, MUMBAI, MAHARASHTRA - 400021, INDIA

-

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2015

(Rs. In Million)

31.03.2014

(Rs. In Million)

SHORT TERM BORROWINGS

 

 

Inter-corporate deposits repayable on demand

78.700

78.700

 

 

 

Total

 

78.700

78.700

 

 

CORPORATE INFORMATION

 

Subject is engaged in business of manufacturing of agro chemicals, speciality chemicals and bulk drugs and its intermediates. The Company has presence in both the domestic and international markets.

 

 

STANDALONE OPERATIONS:

 

The operational results for the year have improved. The efforts of the company to correct the situation, proved meaningful but because of the losses which have to be absorbed due to the correction, the difference was marginal.

 

The disposal of non-profitable businesses and non-core assets reduced the operational and fixed expenses, reduced the debt burden and made the working capital more relevant to the remaining businesses. The Company is now focused on its core business of manufacturing technical agrochemicals.

 

Better operations due to improved raw material efficiencies, implementation of cost saving measures and better working capital management in the Agro Chemicals Division have nurtured the Company back to a positive cash flow situation.

 

The outcome of the efforts of the Management is evident from the results of the financial year 2014-15. The total income on standalone basis during period increased to Rs. 4202.800 Million against the total income of Rs. 391.89crores (excluding income of sold out business and leased unit) in the previous year. The net profit has risen to Rs. 35.600 Million from a marginal profit of Rs. 11.800 Million in the previous year.

 

It may be noted that to restructure the manpower in the Agrochemicals unit at Derabassi, the company offered "Voluntary Retirement Scheme" (VRS) to the employees. 36 employees voluntarily opted for retirement and this reduced the operation costs. The expense on this account has been booked under exceptional item and the result of this onetime cost will be evident in the savings in the years to come.

 

 

OUTLOOK:

 

The global economic environment in recent years has been challenging with uncertainty. It is believed that the growth engine for the global economy would be shifted from west to China and India, the emerging manufacturing and consumption hubs. However, any significant change will be a long drawn process.

 

Therefore, in the given scenario, barring the uncertainties that loom over the industry, the Company expects a good business performance in the agrochemicals sector in the next year. The steps being taken by the government to give more impetus to agriculture sector and promoting the manufacturing sector through "Make in India" programme should further help the Company.

 

The new opportunities of toll manufacturing of Pharma intermediates and other specialized and general chemicals are being explored for both the divisions in Punjab.

 

The Management of the Company is optimistic about the current business prospects and will take requisite steps as and when required.

 

 

FINANCE:

 

As explained earlier, the Company has taken several measures to prune the overall debt burden by entering into Corporate Debt Restructuring Scheme, disposing off the non-profitable business and non-core assets and putting back the cash from the inflows into making the operations of the Company more viable.

 

The Company, during the period has paid the instalments and interest which was due to the Banks, except Working Capital Demand Loan, which is partially paid from the sale of few non-core assets. The Company has not raised any additional borrowing during the year.

 

The Company's proposal for One Time Settlement (OTS) with State Bank of India (SBI) has been accepted by the bank. As per the terms of OTS, the Company has to pay Rs. 455.000 Million and sale proceeds from 1,50,000 shares of the Company, pledged exclusively with SBI by one of the promoters against total outstanding dues of Rs. 948.500 Million (including interest). Out of the said amount, Rs. 113.800 Million has been paid by the Company before March 31, 2015. The said OTS is subject to fulfilment of conditions. The necessary adjustment in the books of account will be carried out after compliance of all conditions as specified in said OTS.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

BUSINESS REVIEW:

 

BUSINESS SEGMENT- AGRO CHEMICALS AND OTHER CHEMICALS

 

INDUSTRY STRUCTURE AND DEVELOPMENT:

 

Economic growth in the Country in the last few years has been depressed, mainly due to higher inflation and depressed domestic demand. However, from this year, the business sentiment has started to improve so also they expect better growth rate. The commitment of the government for better fiscal management and working on macro economic situation has brought positivity in the industrial sentiments.

 

Encouraged by the greater economic stability, institutions like IMF and the World Bank have presented the optimistic growth outlook for India for the year 2015 and beyond. However, subdued demand conditions particularly in Europe and Japan, recent slowdown in China and below normal agricultural growth are the few challenges which may somewhat restrict the growth prospects of the Company.

 

As per the estimates, agro and agro chemical sector is expected to witness good growth in the year 2015. The focus of the Indian government is to achieve higher contribution from agriculture sector to India's GDP growth. The west has started shifting production capacities in the agro chemical segment to developing countries like China and India, this too should bode well for India and the Company.

 

FUTURE PROSPECTS:

 

The Company has a specialized and versatile product portfolio of agrochemicals and industrial chemicals. In view of the growth potential of this Sector, the Management of the Company continues to be positive about the business in future. The Management, with its zeal and sincerity, has managed to establish good business relations with various renowned multi-national Companies for ensuring continuous markets for its products.

 

 

BUSINESS SEGMENT- PHARMA

 

INDUSTRY STRUCTURE AND DEVELOPMENT:

 

Despite economic pressures in healthcare markets and the wider global economy, the resilience shown by the pharmaceutical industry looks set to carry on through 2015. A recent report from Thomson Reuters indicates that global pharmaceutical sales topped $1 trillion last year, following the high-water mark of $980 billion recorded the year before, and this trend is expected to continue.

 

The Company entered into the Pharma business in 2003 after acquisition of erstwhile Alpha Drug India Limited (ADIL), now merged with the Company. However, their product line is restricted to only few bulk drugs, drug intermediates and specialty chemicals at present.

 

PERFORMANCE AND OUTLOOK:

 

As stated above, the growth was slow mainly due to lack of working capital. The Company is engaged in job work where the requirement of working capital is less. This will continue to be their focus till working capital position improves. Since the manufacturing facility has ISO 9001:2000 and ISO 14001: 2004 (which add value and confidence to companies seeking to manufacture) they expect to find additional job work and better utilization of their facilities.

 

 

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.06.2015

 

[RS. IN MILLION]

 

PARTICULARS

Quarter Ended 30.06.2015

 

 (Unaudited)

Income from Operations

 

Gross Sales/ Income from Operations

660.300

Less: Excise Duty

28.100

Net Sales/Income from Operations

632.200

Other Operating Income

33.900

Total Income from operations (net)

666.100

 

 

Expenses

 

(a) Cost of material consumed 

344.100

(b) Purchase of stock in trade

0.000

(c) Changes in inventories of finished goods, work in progress and stock in trade

31.800

(d) Employee benefit expenses

109.900

(e) Depreciation and amortization expenses

41.700

(f) Other Expenses

181.800

Total Expenses

709.300

Profit from Operations before Other Income, Finance costs and Exceptional item

(43.200)

Other Income

44.200

Profit/ Loss from Ordinary Activities before Finance costs and Exceptional item

1.000

Finance costs

55.400

Profit/ Loss from Ordinary Activities after Finance costs but Exceptional item

(54.400)

Exceptional items [Voluntary Retirement Compensation]

--

Profit/ Loss from Ordinary Activities before tax

(54.400)

Tax Expenses

--

Net Profit for the period

(54.400)

Paid- up Equity Share Capital

(Face value of the share – Rs. 10)

122.600

Reserves excluding revaluation reserves as per balance sheet of Previous Accounting Year

--

Basic and diluted earnings per share [Face value of Rs. 10/- each]

 

- Basic and Diluted

(4.44)

 

 

PARTICULARS OF SHAREHOLDING

 

1. Public shareholding

 

Number of Shares

6768318

Percentage of Shareholding

55.20

 

 

2. Promoters and promoter group shareholding

 

a) Pledged/Encumbered

 

- Number of Shares

4245910

- Percentage of Shares (as a % of the Total Shareholding of promoter and promoter group)

77.28

- Percentage of Shares (as a % of the Total Share Capital of the Company)

34.62

 

 

Non - encumbered

 

- Number of Shares

1247957

- Percentage of Shares

(as a % of the total shareholding of promoter and promoter group)

22.72

- Percentage of Shares

(as a % of the total share capital of the company)

10.18

 

 

 

Particulars

Quarter Ended 30.06.2015

B

Investor complaints (Nos.)

 

 

Pending at the beginning of the quarter

Nil

 

Received during the quarter

1

 

Disposed of during the quarter

1

 

Remaining unresolved at the end of the quarter

Nil

 

 

SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED

 

Particulars

Quarter Ended 30.06.2015

 

 (Unaudited)

1. Segment Revenue

 

a. Chemicals 

571.200

b. Bulk Drug and Intermediates 

101.700

Total

672.900

Less: Intersegment Sales

6.800

Total income from operations (net)

666.100

 

 

2. Segment Results

 

Profit/ (loss) before tax and interest

 

a. Chemicals 

39.500

b. Bulk Drug and Intermediates 

(38.400)

Total

1.100

Less: Finance Costs

55.400

Exceptional Items [Income]/ Expense

0.000

Other un-allocable expenditure net off Unallocable Income

0.100

Total Profit Before Tax

(54.400)

 

 

3. Capital Employed

 

(Segment Assets – Segment Liabilities)

 

a. Chemicals 

1824.200

b. Bulk Drug and Intermediates 

614.300

Less: Unallocated

(2301.400)

Total Capital Employed

137.100

 

NOTES:

 

1)       The above standalone financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on August 11, 2015. The Statutory Auditors have carried out the limited review of the above results.

 

2)       The Company’s proposal for One Time Settlement (OTS) with State Bank of India (SBI) has been accepted by the SBI. As per the terms of OTS, the Company has to pay Rs. 455.000 Million and sale proceeds from the 150,000 shares of the Company, pledged exclusively with SBI by one of the promoter against total outstanding dues of Rs. 948.500 Million (including interest). Out of the said amount, Rs. 403.400 Million have been paid by the Company as at June 30, 2015. The said OTS is subject to fulfillment of conditions. The necessary adjustment in the books of account will be carried out after compliance of all conditions as specified.

 

3)       The figures for the quarter ended March 31, 2015 are the balancing figures between the audited figures for the full financial year 2014-15 and the unaudited published figures up to December 31, 2014 being the end of the third quarter of the previous financial year.

 

4)       Figures of the previous period have been regrouped, wherever necessary.

 

 

CONTINGENT LIABILITIES:

 

Particulars

31.03.2015

(Rs. In Million)

31.03.2014

(Rs. In Million)

Claims against the company not acknowledged as debts

 

 

Excise duty matters in dispute or under appeal

57.200

59.900

Income Tax matters in dispute or under appeal

83.000

83.700

Demand raised by Sales Tax Authorities

1.100

1.100

Labour laws matters in dispute or under appeal

1.300

1.300

Demand raised by previous land owners

57.400

49.900

Corporate guarantee given on behalf of the subsidiary companies (revalued at closing exchange rates)

179.100

185.500

 

[Includes Corporate Guarantee given to State Bank of India of Rs. 179.100 Million (Previous year: Rs. 185.500 Million) which is also secured by way of charge on the current assets of the Company and charge on the fixed assets of Agro and Pharmaceutical division.]

 

The Company is contesting the demands and the management, including its tax advisors, believe that its position will be likely be upheld in appellate process. No tax expense has been accrued in financial statements for the tax demand raised. The management believes that the ultimate outcome of the proceeding will not have a material adverse effect on the company's financial position and results of operations. The Company shall indemnify the damages to the Managing Director/Directors in case their personal guarantees are invoked in respect of loans, backed by their personal guarantees.


FIXED ASSETS:

 

·         Land

Buildings

Plant and Equipments

Electrical Installations

Furniture, fixture and equipments

Vehicles

Computer

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 64.97

UK Pound

1

Rs. 100.55

Euro

1

Rs. 73.99

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

KIN

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

4

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.